Evonik strengthens its exclusive synthesis business in US
Evonik acquires Eli Lilly and Company’s U.S. Tippecanoe manufacturing site
Evonik Industries AG has agreed to acquire Indianapolis, Indiana-based Eli Lilly and Company’s Tippecanoe Laboratories manufacturing facility in Lafayette, Indiana. The site, which employs about 700, manufactures active pharmaceutical ingredients (API) and precursor materials for the pharmaceutical industry.
The purchase price was not disclosed. The transaction is expected to close by the end of the year, pending approvals from regulatory agencies.
The Tippecanoe plant will be fully integrated into Evonik’s global production and marketing network.
“The acquisition of Tippecanoe Laboratories enables us to meet the growing demand for intermediates and active pharmaceutical ingredients in the pharmaceutical industry and substantially boosts our global exclusive synthesis business,” said Dr. Klaus Engel, chief executive officer (CEO) of Evonik Industries. “The pharmaceutical market is attractive, economically stable, and produces growth rates near the double-digit range every year.”
In addition to the acquisition of the site, Evonik and Lilly will also enter into a multi-year supplier agreement for active pharmaceutical ingredients and intermediates.
Other news from the department business & finance
These products might interest you
Pharmaceutical Substances by Thieme Verlag
Look up Industrial Syntheses of 2,600 APIs
Your tool for Syntheses, Patents and Applications – Pharmaceutical Substances
AZURA Purifier + LH 2.1 by KNAUER
Preparative Liquid Chromatography - New platform for more throughput
Save time and improve reproducibility during purification
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Last viewed contents
Spin-resolved oscilloscope for charge and spin signals
Sensors made from ‘frozen smoke’ can detect toxic formaldehyde in homes and offices - The proof-of-concept sensors could be adapted to detect a wide range of hazardous gases
Amersham Biosciences Introduces Ettan DIGE Platform for 2-D Fluorescence Difference Gel Electrophoresis - A novel method for differential protein expression analysis
DKSH starts strategic partnership with BASF in Asia
Shell progress on world-scale MEG plant in Singapore
Scientists upcycle polyesters through new waste-free, scalable process - Turning plastic waste into versatile building blocks for organic chemistry
BASF and Sulzer Chemtech sign Memorandum of Understanding to collaborate - Sustainable technologies for renewable fuels and chemically recycled plastics
‘Trustworthy AI’ focus for a new materials and chemicals project - Project to help drive adoption of machine learning wins funding from Innovate UK
Chiron Responds to Novartis Offer
Hermann Klemmt Mess- und Prüftechnik - Aicha, Germany
Merck returns to organic sales growth - Merck raises guidance for 2024
